drugset / Trial / NCT02350725
Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this pilot study is to investigate the pharmacodynamic and pharmacokinetic parameters of a novel furosemide formulation administered subcutaneously as compared to oral furosemide.
Timeline
- Start
- 2014-12
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Furosemide | Other / unclassified | 80 mg | Subcutaneous |